PKM2 either exists in the active tetramers that conventionally catalyzes PEP and ADP into pyruvate and ATP, or forms the less active dimers or inactive monomers to regulate other cellular processes to meet metabolic variations of the tumor cells (Dayton et al, 2016; Mazurek, 2011). The gene discussed is PKM; the disease is neoplasm.